Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the
“Company”), a medical technology company delivering intelligent,
rapid, non-invasive testing solutions, today announced the adoption
of its Intelligent Fingerprinting Drug Screening System by
specialist container logistics firm, VKVP Haulage. Additionally,
the Company announced the successful completion of 25,000
Intelligent Fingerprinting tests with its current customer, Auctus
Management Group.
VKVP Haulage is using random in house
fingerprint sweat-based testing to complement its existing alcohol
testing programme and to support industry best practices across the
company’s 80-strong HGV fleet of trucks.
“The Intelligent Fingerprinting Drug Screening
System is a great testing solution we can use in-house as needed.
The scenario training, the technology and its sample chain of
custody make the fingerprint-based system particularly resilient,
inspiring confidence from both our employees and customers,” said
Roland Hollings, Transport & Fleet Manager at VKVP Haulage. “We
have only been drug testing with the system for a couple of weeks,
but the power of random in-house testing is already having a
positive impact, with both our workforce and our customers
recognizing our commitment to having a proactive drug testing
policy,” he added. “VKVP Haulage operates a fleet of 80 44-tonne
articulated trucks that run across the country carrying containers
for many of the UK’s leading brands, so it’s important we do as
much as possible to ensure safe adherence to our Drug & Alcohol
policy.”
Auctus Management Group has successfully
deployed the Intelligent Fingerprinting Drug Screening System as
part of a comprehensive construction worker induction process,
recently completing 25,000 tests on a major rail construction
project.
Richard Toy, CEO of Auctus Management Group,
explained, “We won the contract to screen and provide employee
inductions for this construction project, one of the largest
construction sites in Europe, and a key differentiator for us was
our proposal to use the Intelligent Fingerprinting Drug Screening
System. This helped our tender stand out against traditional urine
and saliva drug testing alternatives. When we initially looked at
the logistics involved, it simply was not feasible to use
traditional urine-based drug tests, especially because of the need
for dedicated drug test restroom facilities for that many people.
The Intelligent Fingerprinting test has many benefits, including
rapid on-site results, hygiene, non-intrusiveness and convenience
for testing at scale. The test continues to work very well, and we
are proud to now have completed this significant milestone of
25,000 fingerprint drug tests for this particular project.”
Harry Simeonidis, President and CEO of
Intelligent Bio Solutions, said, “It’s fantastic to see that
fingerprint drug testing is rapidly becoming the workplace drug
testing solution of choice for numerous operators across the UK
transportation and logistics sectors, with more and more firms
acknowledging its non-invasive nature and its role in helping to
promote health and safety across operations. The use of our
Intelligent Fingerprinting Drug Screening System by Auctus
Management Group is a great example of the convenience and
efficiency of our Intelligent Fingerprinting solution and
demonstrates how our technology can deliver drug testing at
scale.”
An introductory video demonstrating the
Intelligent Fingerprinting Drug Screening System is available
here.
About Intelligent Bio Solutions
Inc.
Intelligent Bio Solutions Inc. (the "Company")
(Nasdaq: INBS) is a medical technology company delivering
intelligent, rapid, non-invasive testing solutions. The Company
believes that its Intelligent Fingerprinting Drug Screening System
will revolutionize portable testing through fingerprint sweat
analysis, which has the potential for broader applications in
additional fields. This hygienic, and cost-effective system is
designed to screen for recent use of drugs commonly found in the
workplace, including opioids, cocaine, methamphetamine, and
cannabis. With sample collection in seconds and results in under
ten minutes, this technology would be a valuable tool for employers
in safety-critical industries. Additionally, the Company's
biosensor platform has the potential to test for up to 130
indications, ranging from glucose to immunological conditions and
communicable diseases. The Company’s current customer segments
include construction, manufacturing and engineering, transport and
logistics firms, drug treatment organizations, and coroners.
For more information, visit: www.ibs.inc
About VKVP Haulage
VKVP Haulage was founded in 2014 and operates
from its head office in Felixstowe, Suffolk. The company has
continued to expand since its formation and now offers a range of
supply chain services to companies operating across multiple UK
sectors. VKVP Haulage prides itself on providing customers with an
efficient, reliable and professional logistics solution. It
operates a large fleet with all the latest technology, enabling the
company to deliver the highest levels of service.
For more information, visit:
www.vkvp-haulage.co.uk
About Auctus Management
Group
Auctus Management Group leads the
transformation of the UK's infrastructure with rail, civils, and
utilities expertise via its group members, RSS Infrastructure and
INFRA Skills. They provide services ranging from arboriculture to
welding, excel in the delivery of client projects, offer
high-quality training for the rail and construction sectors, and
manage high-profile induction programmes.
For more information, visit:
www.auctusmg.co.uk
Forward-Looking Statements:
Some of the statements in this press release are
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, Section 21E of the Securities Exchange Act
of 1934 and the Private Securities Litigation Reform Act of 1995,
which involve risks and uncertainties. Forward-looking statements
in this press release include, without limitation, Intelligent Bio
Solutions Inc.’s ability to successfully develop and commercialize
its drug and diagnostic tests, realize commercial benefit from its
partnerships and collaborations, and secure regulatory approvals,
among others. Although Intelligent Bio Solutions
Inc. believes that the expectations reflected in such
forward-looking statements are reasonable as of the date made,
expectations may prove to have been materially different from the
results expressed or implied by such forward-looking
statements. Intelligent Bio Solutions Inc. has attempted
to identify forward-looking statements by terminology, including
”believes,” ”estimates,” ”anticipates,” ”expects,” ”plans,”
”projects,” ”intends,” ”potential,” ”may,” ”could,” ”might,”
”will,” ”should,” ”approximately” or other words that convey
uncertainty of future events or outcomes to identify these
forward-looking statements. These statements are only predictions
and involve known and unknown risks, uncertainties, and other
factors, included in Intelligent Bio Solutions’ public filings
filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this release speak only as
of its date. Intelligent Bio Solutions undertakes no obligation to
update any forward-looking statements contained in this release to
reflect events or circumstances occurring after its date or to
reflect the occurrence of unanticipated events.
Company Contact: Intelligent
Bio Solutions Inc. info@ibs.inc
Investor Contact: Valter Pinto,
Managing Director KCSA Strategic Communications PH: (212) 896-1254
INBS@kcsa.com
Media Contact: Cheryl Billson
Comma Communications cheryl.billson@commacomms.com
Intelligent Bio Solutions (NASDAQ:INBS)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Intelligent Bio Solutions (NASDAQ:INBS)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024